This inventor holds 1 USPTO granted patent. Top assignees: Florida Memorial University, University of Kansas. Active years: 2014.
Company Filing History:
1 out of 1 
1 out of 571 
Years Active: 2014
Title: The Innovations of Gerald Carlson
Introduction
Gerald Carlson is an accomplished inventor based in Kansas City, Kansas. He has made significant contributions to the field of biochemistry, particularly through his innovative patent related to enzyme inhibition. His work has implications for various medical and scientific applications.
Latest Patents
Gerald Carlson holds a patent for an inhibitor scaffold designed for the inhibition of the enzyme phosphoenolpyruvate carboxykinase (PEPCK). This PEPCK inhibitor involves identifying a molecule that can fit into and interact with the PEPCK binding site. The patent outlines several key features, including a first terminal substituent with co-planar atoms acting as metal ligands to the active site metal ion of PEPCK. Additionally, it specifies conditions for substituents at positions 2 or 3 from the first terminal substituent, ensuring they possess specific physiochemical properties.
Career Highlights
Throughout his career, Gerald has worked with notable institutions, including the University of Kansas Medical Center Research Institute and Florida Memorial University. His experience in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Gerald has collaborated with talented individuals such as Todd Holyoak and Sarah Sullivan. Their combined expertise has fostered a productive environment for innovation and research.
Conclusion
Gerald Carlson's contributions to enzyme inhibition and his innovative patent highlight his role as a significant figure in the field of biochemistry. His work continues to influence research and development in medical science.